Dr. Subramanian Murali – Medical Oncologist in Bangalore

Dr. Subramanian Murali is a highly experienced Medical Oncologist in Bangalore with more than 24 years of clinical experience in comprehensive cancer care. He specialises in the management of both solid tumors and hematological malignancies using evidence-based systemic therapies.

He holds MBBS, MD in General Medicine and DM in Medical Oncology qualifications, providing him with a strong foundation in internal medicine and advanced cancer treatment.

Dr. Murali has extensive expertise in systemic cancer therapies, including chemotherapy, targeted therapy and immunotherapy. Treatment plans are personalised according to the cancer type, stage, molecular characteristics, overall health and treatment goals of each patient.

His clinical expertise covers comprehensive management of solid tumors and hematological cancers, including advanced and complex malignancies that require multidisciplinary treatment planning and close monitoring.

He also performs specialised oncology procedures including bone marrow aspiration, intrathecal chemotherapy and intraperitoneal chemotherapy as part of appropriate cancer treatment protocols.

Dr. Murali has played an important role in developing day care chemotherapy services in Bangalore and has been instrumental in establishing dedicated chemotherapy infusion centres designed to improve treatment accessibility and patient convenience.

His professional experience includes associations with leading institutions such as Columbia Asia Hospital, Manipal Hospitals, Aster CMI Hospital and Bangalore Baptist Hospital.

He has also contributed significantly to oncology academics and research through peer-reviewed publications, clinical research, medical education and postgraduate training.

Dr. Subramanian Murali currently practises at HCG Hospital, Hebbal, Bengaluru, where he provides personalised and evidence-based medical oncology care.

Medical Oncology

Dr. Subramanian Murali provides comprehensive medical oncology care for patients with solid tumors and hematological malignancies. Treatment is planned according to cancer type, stage, patient health and individual clinical needs.

Chemotherapy

He provides chemotherapy for various cancers using evidence-based protocols. Chemotherapy may be used alone or in combination with surgery, radiation therapy, targeted therapy or immunotherapy depending on the individual treatment plan.

Targeted Therapy

Targeted therapy is used for selected cancers that have specific molecular or genetic characteristics. Treatment selection is based on diagnostic and biomarker findings.

Immunotherapy

Immunotherapy helps stimulate or modify the immune system to recognise and attack cancer cells and may be recommended for suitable patients based on cancer type and clinical condition.

Solid Tumor Treatment

Dr. Murali manages a wide range of solid tumors using systemic cancer treatments including chemotherapy, targeted therapy and immunotherapy where clinically appropriate.

Hematological Cancer Treatment

He also manages hematological malignancies and provides systemic therapy and specialised oncology procedures depending on the specific type and stage of blood cancer.

Bone Marrow Aspiration

Bone marrow aspiration is a diagnostic procedure used to obtain bone marrow samples for evaluation of blood cancers and other hematological conditions.

Intrathecal Chemotherapy

Intrathecal chemotherapy involves delivering anticancer medication directly into the cerebrospinal fluid and may be used in selected hematological malignancies and cancers involving the central nervous system.

Intraperitoneal Chemotherapy

Intraperitoneal chemotherapy delivers anticancer medication directly into the abdominal cavity and may be considered for selected cancers involving the peritoneum.

Advanced Cancer Management

Dr. Murali has extensive experience managing advanced and complex malignancies using personalised systemic treatment strategies and multidisciplinary cancer care.

Day Care Chemotherapy

Day care chemotherapy allows suitable patients to receive planned chemotherapy infusions without requiring prolonged hospital admission, improving treatment convenience while maintaining appropriate monitoring.